Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/14/2013 | US8440609 Peptides against autoantibodies causing intolerance to cold and use thereof |
05/14/2013 | US8440414 Method for monitoring the regulatory activity of chromosome segregation |
05/14/2013 | US8440413 Method of screening for a substance that strengthens a bond between thioredoxin and macrophage migration inhibition factor |
05/14/2013 | US8440391 used for the direct identification of candidate compounds as receptor agonists, inverse agonists or partial agonists having potential applicability as therapeutic agents |
05/14/2013 | US8440204 Subtype of Closteridium botulinum neurotoxin type A and uses thereof |
05/14/2013 | US8440201 Stabilized bioactive peptides and methods of identification, synthesis, and use |
05/14/2013 | US8440200 Using hypoallergenic peptide comprising Phl p 6 molecule to desensitize mammalian allergic response to pollen |
05/14/2013 | US8440196 Treatment for pancreatitis using IL-6 receptor antagonist antibodies |
05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
05/14/2013 | US8440183 Angiogenin complexes (ANGex) with lipid-based substrates and uses thereof |
05/14/2013 | CA2573339C Immune-compromised transgenic mice expressing human hepatocyte growth factor (hhgf) |
05/14/2013 | CA2555463C Inhibitors of tgf-r signaling for treatment of cns disorders |
05/14/2013 | CA2496350C Zinc-regulated prokaryotic expression cassettes |
05/14/2013 | CA2478297C Optimizing glycan processing in plants |
05/14/2013 | CA2477878C Peptides selectively lethal to malignant and transformed mammalian cells |
05/14/2013 | CA2455915C Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
05/14/2013 | CA2453937C Antigenic polypeptides |
05/14/2013 | CA2441562C Short bioactive peptides and methods for their use |
05/14/2013 | CA2434303C Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
05/14/2013 | CA2419469C Derivatives of peptides and peptide mimetics having integrin inhibitor properties ii |
05/14/2013 | CA2393084C Immunoassay for neonicotinyl insecticides |
05/14/2013 | CA2365639C Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
05/14/2013 | CA2263890C Recombinant vascular endothelial cell growth factor d (vegf-d) |
05/14/2013 | CA2260079C Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
05/14/2013 | CA2242342C Isolated dimeric fibroblast activation protein alpha, and uses thereof |
05/10/2013 | WO2013067524A1 Peptides and methods for the detection of lyme disease antibodies |
05/10/2013 | WO2013067509A1 Simultaneous purification of cell components |
05/10/2013 | WO2013067448A2 Compositions and methods to detect various infectious organisms |
05/10/2013 | WO2013067289A1 MtNIP REGULATED PLANTS WITH SIGNIFICANTLY INCREASED SIZE AND BIOMASS |
05/10/2013 | WO2013067133A1 Production of tsg-6 protein |
05/10/2013 | WO2013067128A1 Transgenic plants having increased tolerance to aluminum |
05/10/2013 | WO2013067029A2 Fibronectin binding domains with reduced immunogenicity |
05/10/2013 | WO2013066805A1 Improving plant drought tolerance, nitrogen use efficiency and yield |
05/10/2013 | WO2013066765A1 Mutation of tup1 in glycoengineered yeast |
05/10/2013 | WO2013066733A1 Protective vaccine based on staphylococcus aureus sa2074 protein |
05/10/2013 | WO2013066665A1 Method of rapidly producing improved vaccines for animals |
05/10/2013 | WO2013066365A1 Immunologic constructs and methods |
05/10/2013 | WO2013066264A1 Enzymatic synthesis of cyclic and linear diadenosine monophosphate |
05/10/2013 | WO2013065869A1 Method for secretory production of protein |
05/10/2013 | WO2013065671A1 Method for detecting chronic sinusitis |
05/10/2013 | WO2013065651A1 Protein solution and production method for protein fiber using same |
05/10/2013 | WO2013065650A1 Polypeptide solution, artificial polypeptide fiber production method using same, and polypeptide refining method |
05/10/2013 | WO2013065517A1 Cadmium absorption regulation gene, protein, and rice plant having reduced cadmium absorption |
05/10/2013 | WO2013065302A1 Undifferentiated cell detection method and complex carbohydrate detection method |
05/10/2013 | WO2013064987A1 Plants having increased tolerance to herbicides |
05/10/2013 | WO2013064964A1 Plants having increased tolerance to herbicides |
05/10/2013 | WO2013064934A1 A cellular model for the screening of tdp-43 aggregation affecting molecules |
05/10/2013 | WO2013064700A2 Chimeric polypeptides and methods of use |
05/10/2013 | WO2013064633A1 Oncopeltus peptide derivatives as antimicrobial peptides |
05/10/2013 | WO2013064499A1 Modulating beta-damascenone in plants |
05/10/2013 | WO2013064443A1 In vivo adcc model |
05/10/2013 | WO2013064075A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
05/10/2013 | WO2013064071A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
05/10/2013 | WO2013063713A1 Method for inducing production of comprehensive immune cells |
05/10/2013 | WO2013063695A1 Compositions and methods for preventing and treating oral diseases |
05/10/2013 | WO2013063692A1 Inhibition of collagen synthesis |
05/10/2013 | WO2013063656A1 Gingipain inhibitory propeptides |
05/10/2013 | WO2013040309A3 Wnt compositions and therapeutic uses of such compositions |
05/10/2013 | WO2012171983A3 Method for the production of a polymerized product |
05/10/2013 | WO2012170993A3 Assays and methods pertaining to pre-amyloid intermediates |
05/10/2013 | WO2012169939A3 Recombinant dna elements for the expression of recombinant proteins in a host cell |
05/10/2013 | WO2012128628A9 Immunogenic compositions in particulate form and methods for producing the same |
05/10/2013 | WO2010125566A3 Markers for cancer detection |
05/10/2013 | CA2854327A1 Mtnip regulated plants with significantly increased size and biomass |
05/10/2013 | CA2854202A1 Inhibition of collagen synthesis |
05/10/2013 | CA2853857A1 Compositions and methods for preventing and treating oral diseases |
05/10/2013 | CA2853775A1 Improving plant drought tolerance, nitrogen use efficiency and yield |
05/10/2013 | CA2853671A1 Medical use |
05/10/2013 | CA2853464A1 Undifferentiated cell detection method and complex carbohydrate detection method |
05/10/2013 | CA2853320A1 Modulating beta-damascenone in plants |
05/10/2013 | CA2853292A1 Transgenic pig models of cystic fibrosis |
05/10/2013 | CA2851540A1 Peptides and methods for the detection of lyme disease antibodies |
05/10/2013 | CA2851419A1 Plants having increased tolerance to herbicides |
05/10/2013 | CA2849866A1 In vivo adcc model |
05/10/2013 | CA2849060A1 Plants having increased tolerance to herbicides |
05/09/2013 | US20130117891 Growth promoting fusion proteins |
05/09/2013 | US20130117879 Plant Eukaryotic Translation Initiation Factor 4E |
05/09/2013 | US20130117872 Novel Substitution Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System |
05/09/2013 | US20130116410 New stabilizing agent for pharmaceutical proteins |
05/09/2013 | US20130116409 Method for Enriching Methylated CpG Sequences |
05/09/2013 | US20130116408 Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy |
05/09/2013 | US20130116405 Compositions comprising modified collagen and uses therefor |
05/09/2013 | US20130116342 Salt-resistant emulsions |
05/09/2013 | US20130116305 Methods and compositions for the inhibition of hiv-1 replication |
05/09/2013 | US20130116201 Use of peptides as transporters intended for the internalization of molecules of interest into target cells |
05/09/2013 | US20130116191 Transport protein which is used to introduce chemical compounds into nerve cells |
05/09/2013 | US20130116189 Retinol-modified collagen, method for producing same, and external composition for skin containing same |
05/09/2013 | US20130116185 Phosphatidylinositol 3-kinases activity regulator including the fifth zinc finger domain of fog2 |
05/09/2013 | US20130116182 Factor VIII B Cell Epitope Variants Having Reduced Immunogenicity |
05/09/2013 | US20130116180 Parathyroid hormone analogs and uses thereof |
05/09/2013 | US20130116176 Derivatisation of erythropoietin (epo) |
05/09/2013 | US20130116173 Glucagon Analogs Exhibiting GIP Receptor Activity |
05/09/2013 | US20130116172 Glucagon superfamily peptides exhbiting g protein coupled receptor activity |
05/09/2013 | US20130116168 Pea protein peptides with anti helicobacter pylori activity |
05/09/2013 | US20130116167 Anti-mart-1 t cell receptors and related materials and methods of use |
05/09/2013 | US20130115682 Fusion proteins |
05/09/2013 | US20130115636 Histone citrullinated peptides and uses thereof |
05/09/2013 | US20130115634 Peptides and methods for the detection of lyme disease antibodies |
05/09/2013 | US20130115625 Novel protein and use thereof |
05/09/2013 | US20130115620 Novel Hemopoietin Receptor Protein, NR10 |